COMMUNIQUÉS West-GlobeNewswire
-
Sanofi: Dupixent® (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps
16/10/2018 - 07:01 -
Sanofi : Premiers résultats positifs de deux essais de phase III consacrés au Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne
16/10/2018 - 07:01 -
VALNEVA Announces Progress of Chikungunya Vaccine Candidate
16/10/2018 - 07:01 -
VALNEVA annonce la progression du développement de son candidat vaccin contre le Chikungunya
16/10/2018 - 07:01 -
INNATE PHARMA : data presentations on monalizumab at the ESMO annual meeting 2018
16/10/2018 - 07:01 -
INNATE PHARMA : présentation de données pour monalizumab lors du congrès annuel ESMO
16/10/2018 - 07:01 -
Probiodrug publishes SAPHIR data in peer reviewed journal
16/10/2018 - 07:00 -
ICC Labs Provides Information About Circular
16/10/2018 - 02:34 -
OpGen Provides Business and Preliminary Financial Update
15/10/2018 - 23:35 -
Emblem Establishes Temporary “Patient Access Investment Fund” to Partially Cover Medical Cannabis Excise Tax
15/10/2018 - 22:41 -
aTyr Pharma Announces Leadership Transition
15/10/2018 - 22:30 -
Emergent BioSolutions Completes Acquisition of Adapt Pharma and Flagship Product Narcan® (Naloxone HCI) Nasal Spray
15/10/2018 - 22:30 -
B. Braun Premieres Its New Wireless Syringe Pump at NANN 2018
15/10/2018 - 22:29 -
GenMark Diagnostics Schedules Third Quarter Financial Results Conference Call for October 29, 2018
15/10/2018 - 22:05 -
Aclaris Therapeutics to Acquire Worldwide Rights to RHOFADE® from Allergan
15/10/2018 - 22:01 -
Pediapharm annonce la clôture de l’offre de reçus de souscription pour un produit brut total de 62 M$
15/10/2018 - 20:21 -
Welldoc Announces Expansion of Program with Leading Academic Medical Center to Evaluate BlueStar® Digital Therapeutic as a Means of Transforming Population Health in Primary Care
15/10/2018 - 19:00 -
Sanofi: Disclosure of trading in own shares
15/10/2018 - 18:01 -
Sanofi : Déclaration des transactions sur actions propres
15/10/2018 - 18:01
Pages